Ximino

Active Ingredient(s): Minocycline Hydrochloride
FDA Approved: * July 11, 2012
Pharm Company: * RANBAXY LABS LTD
Category: Antibiotics

Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as pneumonia.[2][5] It is generally less preferred than the tetracycline doxycycline.[2][5] It is also used for the treatment of acne and rheumatoid arthritis.[5][6] It is taken by mouth or applied to the skin.[2][6]... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

24 Hr Ximino 45 mg Extended Release Capsule
NDC: 10631-330
Labeler:
Ranbaxy Laboratories Inc.
24 Hr Ximino 90 mg Extended Release Capsule
NDC: 10631-331
Labeler:
Ranbaxy Laboratories Inc.
24 Hr Ximino 135 mg Extended Release Capsule
NDC: 10631-332
Labeler:
Ranbaxy Laboratories Inc.
Ximino 45 mg Oral Capsule, Extended Release
NDC: 69489-121
Labeler:
Journey Medical Corporation
Ximino 90 mg Oral Capsule, Extended Release
NDC: 69489-122
Labeler:
Journey Medical Corporation
Ximino 135 mg Oral Capsule, Extended Release
NDC: 69489-123
Labeler:
Journey Medical Corporation

Related Brands

Drugs with the same active ingredients